← Back to news

Markets

Amazon Stock in 2026: Key Catalysts and What Investors Should Watch

Y

Private Equity must Invest 'Dry Powder' or Risk an Investor Exodus

Y

Which Small-Cap ETF Is Better: Vanguard's VB or iShares' ISCB?

Y

If You'd Invested $500 in Netflix 10 Years Ago, Here's How Much You'd Have Today

Y

After my divorce I ended up with a truck $7K underwater. Here are the best ways to manage your debt

Y

Stocks enter final stretch of 2025 just off record highs: What to watch this week

Y

Coty Completes Wella Divestment to Refocus on Fragrances

Y

Denison Mines Forms Joint Ventures With Skyharbour

Y

Jefferies Sees Structural Strength but Limited Upside for UWM Holdings Corporation (UWMC)

Y

Wall Street Keeps B2Gold Corp. (BTG) in Focus With Mixed Views

Y

BlackBerry Limited (BB) Outperforms Estimates but RBC Sticks With Sector Perform

Y

Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy?

Y

NIO Inc. (NIO) Holds Mixed Analyst Sentiment Despite Strong Median Upside Potential

Y

Clarivate Plc (CLVT) Downgraded Amid Turnaround Challenges

Y

Cosan S.A. (CSAN) Gets Negative Outlook from Fitch as Leverage Remains High

Y

Could This Bear-Market Buy Help You Become a Millionaire?

Y

Prediction: These 3 Stocks Will Join the $3 Trillion Club in 2026

Y

Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study

Y

Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program

Y

High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin

Y

Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data

Y

Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR)

Y

Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change

Y

Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress

Y

TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy”

Y

Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives

Y

Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress

Y

H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result

Y

Compass Therapeutics’ (CMPX) Tovecimig Drives Strong Analyst Sentiment

Y

Nike Beat Big, But The Market Heard One Word: Tariffs

Y

Is AI really killing finance and banking jobs? Experts say Wall Street’s layoffs may be more hype than takeover—for now

Y

Dividend Stocks Worth Betting On For The 2026 Income Supercycle

S

5 crystal-clear signs you’ve retired (very) well in America. Can you finally stop stressing out in 2026?

Y

Do you really need $1 million in savings to retire comfortably? 'It depends' says JPMorgan

Y

1 Quantum Computing Stock to Buy Hand Over Fist in December

Y

Should You Buy SMR While It's Under $20?

Y

My Ultimate Low-Stress Retirement Portfolio For Reliable Income

S

Retirement Savings in Your 70s: How You Compare to Others?

Y

Better Buy: XRP vs. Dogecoin

Y

Here’s Who Should Really Be Worried About Social Security Cuts

Y

Better Crypto Buy: Bitcoin vs. XRP

Y

Fed's Hammack signals holding rates steady for months, WSJ reports

Y

Wall Street Week Ahead

S

Is Palantir the Top Artificial Intelligence Stock for 2026?

Y

The Rules for Working While Collecting Social Security Are Changing in 2026

Y

We Lost Our Home in a Wildfire: Here’s the Harsh Reality of Mortgage Relief

Y

Will the S&P 500 Post Double-Digit Returns in 2026 for a 4th Consecutive Year? Here's What History Says.

Y

HELOC rates today, December 21, 2025: A holiday cash flow solution gets a rate break

Y

Best money market account rates today, December 21, 2025 (best account provides 4.25% APY)

Y

Best CD rates today, December 21, 2025 (lock in up to 4.1% APY)

Y